Essen, Germany/Kennesaw, GA, USA. Evonik has entered into an agreement to supply blueSulfate®, a liquid ammonium sulfate (8-0-0-9) solution from its site in Mobile, Alabama, to Interoceanic Corporation (IOC). This agreement supports Evonik’s strategy to focus on its core business in Animal Nutrition by marketing high-value co-products of its methionine production network for fertilizing crops via IOC. Interoceanic is a marketer of fertilizer and industrial chemicals with a terminal network and multi-modal transportation fleet in North America, linking producers and end users.
This joint effort allows Evonik to bring valuable nitrogen fertilizer to the market that meets the needs of US farmers, contributing to the circularity of macronutrients in agriculture. Evonik manufactures liquid ammonium sulfate (8-0-0-9) solution and a potassium-based fertilizer, AgraLi®, as co-products of its methionine production.
“This agreement was the result of a lot of hard work and forward- thinking by both Evonik and IOC to provide additional products to both American Agriculture and a growing population,” states Doug Mills, Plant Nutrition Business Manager at the Nutrition & Care division of Evonik. “We look forward to a successful relationship with IOC.”
Evonik is one of the world leaders in specialty chemicals. The company is active in more than 100 countries around the world and generated sales of €15 billion and an operating profit (adjusted EBITDA) of €2.38 billion in 2021. Evonik goes far beyond chemistry to create innovative, profitable and sustainable solutions for customers. About 33,000 employees work together for a common purpose: We want to improve life today and tomorrow.
About Nutrition & Care
The focus of the business of the Nutrition & Care division is on health and quality of life. It develops differentiated solutions for active pharmaceutical ingredients, medical devices, nutrition for humans and animals, personal care, cosmetics, and household cleaning. In these resilient end markets, the division generated sales of €3.56 billion in 2021 with about 5,300 employees.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.